Skip to main content
. 2017 Dec 17;9(3):3853–3866. doi: 10.18632/oncotarget.23380

Table 1A. Patient information.

ID Disease stage Age (at sampling) Sex
ALL001 Pre-treatment NK NK
ALL002 Follow-up 19 Male
ALL003 Pre-treatment 24 Male
ALL004 Diagnosis 22 Male
ALL005 Diagnosis 64 Male
ALL006 Pre-treatment 19 Male
ALL007 Diagnosis 19 Male
ALL008 Pre-treatment 19 Female
ALL009 Diagnosis 49 Male
ALL010 Diagnosis 19 Male
ALL011 Pre-treatment 18 Male
ALL012 Diagnosis 52 Female
ALL013 Pre-treatment 52 Male

NK, not known.